Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | EVP - Specialty & Corp Dev | September 18, 2018 | September 20, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date September 18, 2018 · Filed September 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $151.85 · Expires 2028-09-18 | Direct | 19,040 |
Reported balance
After 2018-09-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-09-18 · Grant · Acquired 19,040 · Balance 19,040 F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2018 Filed Sep 20, 2018 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 19,040 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-18-013639 · doc4.xml · derivative · entry 1 Balousek Jon M · CIK 0001565181 · EVP - Specialty & Corp Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,040 Underlying: Common Stock · 19,040 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 20:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 3,354 | $144.73 | $485,408.66 |
DisclosureSEC source: 0001225208-18-012983 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · EVP - Specialty & Corp Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,545 F1 · price: This transaction was executed in multiple trades at prices ranging from $144.72 to $144.738. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 201 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 70 | $146.77 | $10,273.90 |
DisclosureSEC source: 0001225208-18-012767 · doc4.xml · nonDerivative · entry 2 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,698 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 3,030 | $146.77 | $444,713.10 |
DisclosureSEC source: 0001225208-18-012767 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,768 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 20,470 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-17-015010 · doc4.xml · derivative · entry 2 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,470 Underlying: Common Stock · 20,470 shares Expires 2027-09-12 F2 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F2 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| September 08, 2017 Filed Sep 14, 2017 21:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GiftCommon Stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015010 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,738 F1 · kind: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 20:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,387 | $0.00 Strike: $72.11 | $0.00 |
DisclosureSEC source: 0001225208-17-014366 · doc4.xml · derivative · entry 5 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,387 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 20:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,707 | $0.00 Strike: $74.09 | $0.00 |
DisclosureSEC source: 0001225208-17-014366 · doc4.xml · derivative · entry 4 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,707 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 20:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 9,223 | $138.87 | $1,280,822.91 |
DisclosureSEC source: 0001225208-17-014366 · doc4.xml · nonDerivative · entry 3 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,098 F1 · price: This transaction was executed in multiple trades at prices ranging from $138.767 to $139.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 20:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 1,707 | $74.09 | $126,471.63 |
DisclosureSEC source: 0001225208-17-014366 · doc4.xml · nonDerivative · entry 2 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 20:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 5,387 | $72.11 | $388,456.57 |
DisclosureSEC source: 0001225208-17-014366 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:11 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 83 | $137.17 | $11,385.11 |
DisclosureSEC source: 0001225208-17-014218 · doc4.xml · nonDerivative · entry 2 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,227 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:11 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 3,572 | $137.17 | $489,971.24 |
DisclosureSEC source: 0001225208-17-014218 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,310 F1 · kind: Settlement of 2014 Performance Unit Grant that vested 8/17/2017, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 23:12 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,490 | $134.54 | $200,464.60 |
DisclosureSEC source: 0001225208-17-007694 · doc4.xml · nonDerivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,738 F1 · kind: The Restricted Stock Units will vest on the third anniversary of the grant date. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 20:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 17,290 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-16-039403 · doc4.xml · derivative · entry 1 Balousek Jon M · CIK 0001565181 · SVP - GM, Specialty Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,290 Underlying: Common Stock · 17,290 shares Expires 2026-09-13 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.